Dr Reddy's Labs plunged 10%, ends as top Sensex loserThe company had reported a net profit of Rs 626 crore for the same quarter last year. This marks the second straight quarter of decline in ...
27 Jul, 2016, 04.52 PM IST
Dr Reddy's tanks over 3% ahead of Q1 resultsAt 01:18 pm, shares of the company traded at Rs 3,489.90 apiece, down 3.20 per cent from its previous close on the Bombay Stock Exchange (B...
25 Jul, 2016, 07.11 PM IST
Mapping the market: Supercharged PSUs & 221 stocks that made Rs 1L croreMarket barometer Nifty50 closed at 8,636, up 1.11%, after hitting a fresh 52-wk high during the session while the Sensex ended 1.05% higher...
25 Jul, 2016, 04.49 PM IST
- Neutral on Dr Reddy's Laboratories with a target at Rs 3070: Credit Suisse
Credit Suisse also slashed its earnings forecast as they incorporate hit in Valcyte and Vidaza.
13 May, 2016, 12.39 PM IST
Planning to dump Dr Reddy's from your portfolio post Q4 numbers? Think twiceMost global brokerage firms maintained a positive view on the stock post March quarter results and CLSA has even raised its 12-month target...
13 May, 2016, 11.09 AM IST
Have the heart? Top 10 multibagger opportunities to look atThe tussle between the bulls and the bears is clearly giving sleepless nights to investors, who made a comeback to the equity market in cal...
12 Feb, 2016, 04.15 PM IST
20 stock picks from top brokerages for New YearAn ETMarkets.com survey among the brokerages showed most experts expect the benchmark equity indices to move in the 27,000-31,000 range.
04 Jan, 2016, 04.16 PM IST
Sensex may fall by another 1000 points; top 10 stocks to buy on declinesBoth Sensex and Nifty recorded their fresh 52-week lows on Friday amid nervousness over an interest rate hike by the US Federal Reserve.
04 Sep, 2015, 03.37 PM IST
Natco Pharma shines on hopes of Dilip Shanghvi stake hike, new launchesHopes of some high value launches over the next few months have also boosted sentiment in the stock. It has risen as much as 60% so far in ...
11 Apr, 2015, 07.08 AM IST
Intas launches cheaper generic blood cancer drugIntas is manufacturing Azadine at its Ahmedabad facility, which operates in compliance with global regulatory standards like USFDA, MHRA an...
20 Jul, 2014, 11.56 AM IST
Intas Pharmaceuticals prices generic onco-drug at one-fifth of current costIn MDS, the bone marrow does not make enough healthy blood cells and there are abnormal cells present, leading to leukaemia in advanced sta...
26 Jun, 2014, 10.26 AM IST
Pharma companies to witness 26 per cent core sales growth in Q3: BoAMLThe increasing number of limited-competition products is rendering higher sustainable growth to the base business.
12 Jan, 2014, 11.37 AM IST
Dr. Reddy’s & Sun Pharma to see strong Q3 earnings growth: Arvind Bothra, Religare"Lupin would have a stable revenue growth merely because some of the recent launches that they have had have been in the latter part of the...
06 Jan, 2014, 04.22 PM IST
How brokerages rate DRL, Lupin, Airtel, Idea and Maruti post resultsA look at report cards brought out by DRL, Lupin, Airtel, Idea and Maruti last week, shows that earnings have so far been better than expec...
04 Nov, 2013, 08.50 PM IST
Brokerages raise price target on Dr Reddy's to as high as Rs 2,720 on FDA nodBrokerages see the FDA approval to Dr Reddy’s Laboratories (DRL) for generic Vidaza as a positive for the company.
18 Sep, 2013, 12.29 PM IST
USFDA approves DRL's Azacitidine for injectionAzacitidine is used to treat certain types of bone marrow cancers and blood cell disorders. Dr Reddy's Azacitidine for injection is availab...
17 Sep, 2013, 01.32 PM IST